FDA Inspection 1085127 — OneBlood, Inc.

OneBlood, Inc. — FEI 1077496

The FDA completed an inspection of OneBlood, Inc. on Apr 2, 2019 in Fort Lauderdale, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 2, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Lauderdale, FL (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
326421 CFR 820.250(b)Sampling methods - Lack of or inadequate procedures
44721 CFR 820.40Lack of procedures, or not maintained
63021 CFR 803.17Lack of Written MDR Procedures

Need the full FDA record for OneBlood, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.